Akero Therapeutics, Inc.

Historical 13F Holders

Symbol
AKRO
CUSIP
00973Y108
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 21 322 k $8.00 M
2023 Q4 175 59.6 M $1.39 B
2023 Q3 219 57.1 M $2.89 B
2023 Q2 179 56.2 M $2.63 B
2023 Q1 173 47.8 M $1.83 B
2022 Q4 185 51.1 M $2.80 B
2022 Q3 171 51.0 M $1.73 B
2022 Q2 115 36.7 M $347 M
2022 Q1 106 35.2 M $499 M
2021 Q4 104 35.4 M $749 M
2021 Q3 107 28.0 M $626 M
2021 Q2 101 27.7 M $701 M
2021 Q1 119 31.5 M $914 M
2020 Q4 102 30.9 M $816 M
2020 Q3 109 29.0 M $892 M
2020 Q2 83 21.9 M $545 M
2020 Q1 70 22.1 M $468 M
2019 Q4 59 19.1 M $423 M
2019 Q3 56 12.7 M $288 M
2019 Q2 49 10.7 M $205 M